These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37788604)

  • 1. Survey of Buprenorphine Low-dose Regimens Used by Healthcare Institutions.
    Hardy M; Grable S; Otley R; Pershing M
    J Addict Med; 2023 Sep-Oct 01; 17(5):521-527. PubMed ID: 37788604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study.
    Baumgartner K; Salmo E; Liss D; Devgun J; Mullins M; Galati B; Kelly J; Schwarz E
    Clin Toxicol (Phila); 2022 Jun; 60(6):688-693. PubMed ID: 35048759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine Microdosing for the Pain and Palliative Care Clinician.
    Quirk K; Stevenson M
    J Palliat Med; 2022 Jan; 25(1):145-154. PubMed ID: 34978915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series.
    Suen LW; Lee TG; Silva M; Walton P; Coffin PO; Geier M; Soran CS
    J Addict Med; 2022 Sep-Oct 01; 16(5):534-540. PubMed ID: 35149614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an intravenous low-dose buprenorphine initiation protocol.
    Jablonski LA; Bodnar AR; Stewart RW
    Drug Alcohol Depend; 2022 Aug; 237():109541. PubMed ID: 35753281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.
    Azar P; Wong JSH; Mathew N; Vogel M; Perrone J; Herring AA; Krausz RM; Montaner JSG; Greenwald MK; Maharaj AR
    J Addict Med; 2023 Mar-Apr 01; 17(2):233-236. PubMed ID: 36149002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.
    Thakrar AP; Jablonski L; Ratner J; Rastegar DA
    J Addict Med; 2022 Jan-Feb 01; 16(1):122-124. PubMed ID: 33758112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine Microdosing Cross Tapers: A Time for Change.
    Raheemullah A; Benhamou OM; Kuo J; Lembke A
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Howard Street Method: A Community Pharmacy-led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl.
    Noel M; Abbs E; Suen L; Samuel L; Dobbins S; Geier M; Soran CS
    J Addict Med; 2023 Jul-Aug 01; 17(4):e255-e261. PubMed ID: 37579105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Neuropharmacological Model to Explain Buprenorphine Induction Challenges.
    Greenwald MK; Herring AA; Perrone J; Nelson LS; Azar P
    Ann Emerg Med; 2022 Dec; 80(6):509-524. PubMed ID: 35940992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.
    Murray JP; Pucci G; Weyer G; Ari M; Dickson S; Kerins A
    Addict Sci Clin Pract; 2023 Jun; 18(1):38. PubMed ID: 37264449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl.
    Spadaro A; Sarker A; Hogg-Bremer W; Love JS; O'Donnell N; Nelson LS; Perrone J
    Clin Toxicol (Phila); 2022 Jun; 60(6):694-701. PubMed ID: 35119337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: "Ultrarapid Micro-Dosing" Proof of Concept.
    Azar P; Mathew N; Mahal D; Wong JSH; Westenberg JN; Schütz CG; Greenwald MK
    J Psychoactive Drugs; 2023; 55(1):94-101. PubMed ID: 35152847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes.
    DeWeese JP; Krenz JR; Wakeman SE; Peckham AM
    Subst Abus; 2021; 42(4):506-511. PubMed ID: 33945452
    [No Abstract]   [Full Text] [Related]  

  • 17. Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.
    Azar P; Nikoo M; Miles I
    Am J Addict; 2018 Dec; 27(8):601-604. PubMed ID: 30387894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Initiation of Buprenorphine: A Narrative Review.
    Edinoff AN; Fahmy OH; Spillers NJ; Zaheri AR; Jackson ED; De Witt AJ; Wenger DM; Cornett EM; Skidmore KL; Kaye AM; Kaye AD
    Curr Pain Headache Rep; 2023 Jul; 27(7):175-181. PubMed ID: 37083890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Inductions via Transdermal Patches for Opioid Use Disorder in the Inpatient Setting.
    Porras H; Johnson E; Kotova M; Chenoweth J; Colby D
    J Pain Palliat Care Pharmacother; 2023 Sep; 37(3):251-256. PubMed ID: 37326470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl - Case report.
    Kaliamurthy S; Jegede O; Hermes G
    J Addict Dis; 2023; 41(2):175-180. PubMed ID: 35377273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.